Bristol-Myers pursues OTC sales for Pravachol
No surprise here. Statins have been OTC in Britain for the past year or so. Incidentally Pravachol is Bristol-Myers’ biggest seller, and its patent will be expiring soon. This is purely money-based – don’t believe anything about “health benefits” that the drug company claiming is behind the move.
